Mark Lawler: Protecting cancer survivors from financial discrimination
Mark Lawler shared a post about cancer survivors facing financial discrimination. Read his post on X below:
“Protecting cancer survivors from financial discrimination is not about compassion; it’s about evidence.
When a specialist says you are cured and international benchmarking agrees, what authority do financial institutions have to say you’re not?”
More posts featuring Mark Lawler.
Dr. Mark Lawler is the Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, Centre for Cancer Research and Cell Biology. He is also a Visiting Professor in Human Genetics and Molecular Medicine at the University of Chieti Pescara, Italy.
His specialties include genetics, molecular medicine, cancer biology, drug discovery, graduate education, bioethics, science policy, art therapy, and public perception of science.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023